牛牛AI助理已提取核心訊息
Moderna, Inc. Director NOUBAR B AFEYAN is set to sell 15,000 shares of the company's common stock on 04/03/2024, with an aggregate market value of $1,554,150. The shares were originally acquired on 05/01/2012 through a private placement from the issuer, with a cash payment. This upcoming sale is part of a series of transactions, as AFEYAN has sold a total of 45,000 shares in the past three months, amounting to gross proceeds of $4,799,715. The notice of the planned sale was filed on the same date as the intended sale, with the plan for these transactions having been adopted on 11/07/2023.
Moderna, Inc. Director NOUBAR B AFEYAN is set to sell 15,000 shares of the company's common stock on 04/03/2024, with an aggregate market value of $1,554,150. The shares were originally acquired on 05/01/2012 through a private placement from the issuer, with a cash payment. This upcoming sale is part of a series of transactions, as AFEYAN has sold a total of 45,000 shares in the past three months, amounting to gross proceeds of $4,799,715. The notice of the planned sale was filed on the same date as the intended sale, with the plan for these transactions having been adopted on 11/07/2023.
Moderna, Inc.董事NOUBAR B AFEYAN定於2024年3月4日出售該公司15,000股普通股，總市值爲1,554,150美元。這些股票最初於2012年1月5日通過發行人的私募收購，並以現金支付。即將進行的出售是一系列交易的一部分，因爲AFEYAN在過去三個月中共出售了45,000股股票，總收益爲4,799,715美元。計劃出售通知與預期銷售的同一天提交，這些交易的計劃已於2023年7月11日通過。
Moderna, Inc.董事NOUBAR B AFEYAN定於2024年3月4日出售該公司15,000股普通股，總市值爲1,554,150美元。這些股票最初於2012年1月5日通過發行人的私募收購，並以現金支付。即將進行的出售是一系列交易的一部分，因爲AFEYAN在過去三個月中共出售了45,000股股票，總收益爲4,799,715美元。計劃出售通知與預期銷售的同一天提交，這些交易的計劃已於2023年7月11日通過。
有用
沒用